iBio Inc (IBIO)
2.28
-0.02
(-0.87%)
USD |
NYAM |
Jun 18, 16:00
2.32
+0.04
(+1.75%)
Pre-Market: 08:00
iBio Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 12.62M |
June 30, 2023 | 12.94M |
March 31, 2023 | 13.70M |
December 31, 2022 | 16.01M |
September 30, 2022 | 22.20M |
June 30, 2022 | 22.16M |
March 31, 2022 | 22.12M |
December 31, 2021 | 22.05M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.60M |
March 31, 2021 | 0.60M |
December 31, 2020 | 0.60M |
September 30, 2020 | 0.60M |
June 30, 2020 | 0.60M |
March 31, 2020 | 1.196M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
22.20M
Maximum
Sep 2022
8.222M
Average
0.898M
Median
Total Long Term Debt (Quarterly) Benchmarks
Lixte Biotechnology Holdings Inc | -- |
PAVmed Inc | 45.54M |
Avalo Therapeutics Inc | -- |
Imunon Inc | -- |
Ocugen Inc | 2.829M |